Literature DB >> 4074616

Stereoselective disposition of indoprofen in surgical patients.

S Björkman.   

Abstract

The pharmacokinetics of the enantiomers of indoprofen were determined after intravenous administration of the racemate to 10 surgical patients. The mean volume of distribution was 8.97 +/- 2.21 (s.d.) 1 for the pharmacologically active S(+)-enantiomer and 12.60 +/- 4.21 1 for the R(-)-enantiomer (P less than 0.001). The corresponding values for clearance were 32.2 +/- 11.1 ml min-1 and 48.8 +/- 15.5 ml min-1 (P less than 0.001). There was no significant difference in mean terminal half-life between the enantiomers.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4074616      PMCID: PMC1400712          DOI: 10.1111/j.1365-2125.1985.tb05098.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

1.  Enzymatic inversion at saturated carbon: nature and mechanism of the inversion of R(-) p-iso-butyl hydratropic acid.

Authors:  W J Wechter; D G Loughhead; R J Reischer; G J VanGiessen; D G Kaiser
Journal:  Biochem Biophys Res Commun       Date:  1974-12-11       Impact factor: 3.575

2.  GLC determination of plasma levels of enantiomers of alpha-(4-(1-oxo-2-isoindolinyl)phenyl)propionic acid.

Authors:  G P Tosolini; E Moro; A Forgione; M Ranghieri; V Mandelli
Journal:  J Pharm Sci       Date:  1974-07       Impact factor: 3.534

3.  Biological activity of indoprofen and its optical isomers.

Authors:  A Buttinoni; M Ferrari; M Colombo; R Ceserani
Journal:  J Pharm Pharmacol       Date:  1983-09       Impact factor: 3.765

4.  High-performance liquid chromatographic determination of stereoselective disposition of carprofen in humans.

Authors:  J K Stoltenborg; C V Puglisi; F Rubio; F M Vane
Journal:  J Pharm Sci       Date:  1981-11       Impact factor: 3.534

5.  Determination of the enantiomers of indoprofen in blood plasma by high-performance liquid chromatography after rapid derivatization by means of ethyl chloroformate.

Authors:  S Björkman
Journal:  J Chromatogr       Date:  1985-05-03

6.  GLC determination of ibuprofen [dl-2-(p-isobutylphenyl) propionic acid] enantiomers in biological specimens.

Authors:  G J Vangiessen; D G Kaiser
Journal:  J Pharm Sci       Date:  1975-05       Impact factor: 3.534

7.  Stereoselective inversion of (R)-fenoprofen to (S)-fenoprofen in humans.

Authors:  A Rubin; M P Knadler; P P Ho; L D Bechtol; R L Wolen
Journal:  J Pharm Sci       Date:  1985-01       Impact factor: 3.534

8.  Stereoselective inversion of (R)-(-)-benoxaprofen to the (S)-(+)-enantiomer in humans.

Authors:  R J Bopp; J F Nash; A S Ridolfo; E R Shepard
Journal:  Drug Metab Dispos       Date:  1979 Nov-Dec       Impact factor: 3.922

9.  Stereospecific inversion of (R)-(-)-benoxaprofen in rat and man.

Authors:  R G Simmonds; T J Woodage; S M Duff; J N Green
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1980       Impact factor: 2.441

10.  Pharmacokinetics of the enantiomers of indoprofen in man.

Authors:  V Tamassia; M G Jannuzzo; E Moro; S Stegnjaich; W Groppi; F B Nicolis
Journal:  Int J Clin Pharmacol Res       Date:  1984
View more
  4 in total

Review 1.  Stereoselectivity in clinical pharmacokinetics and drug development.

Authors:  D B Campbell
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

Review 2.  Enantioselective pharmacodynamics and pharmacokinetics of chiral non-steroidal anti-inflammatory drugs.

Authors:  A M Evans
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 3.  Pharmacokinetics of enantiomers of chiral non-steroidal anti-inflammatory drugs.

Authors:  F Jamali
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Jan-Mar       Impact factor: 2.441

Review 4.  Protein binding and stereoselectivity of nonsteroidal anti-inflammatory drugs.

Authors:  F Lapicque; N Muller; E Payan; N Dubois; P Netter
Journal:  Clin Pharmacokinet       Date:  1993-08       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.